1. National Cancer Institute. Surveillance Epidemiology and End Results [online] , (2011).
2. DeLellis, R. A., Lloyd, R. V., Heitz, P. U. & Eng, C. (Eds) World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Endocrine Organs. (IARC Press, Lyon, 2004).
3. Mazzaferri, E. L. & Jhiang, S. M. Differentiated thyroid cancer long-term impact of initial therapy. Trans. Am. Clin. Climatol. Assoc. 106, 151–168 (1995).
4. Eustatia-Rutten, C. F. et al. Survival and death causes in differentiated thyroid carcinoma. J. Clin. Endocrinol. Metab. 91, 313–319 (2006).
5. Dohan, O. et al. The sodium/iodide symporter (NIS): characterization, regulation, and medical significance. Endocr. Rev. 24, 48–77 (2003).